Amplia Therapeutics Ltd (ATX)

Sydney
0.170
-0.005(-2.86%)
  • Volume:
    111,245
  • Bid/Ask:
    0.170/0.175
  • Day's Range:
    0.170 - 0.170

ATX Overview

Prev. Close
0.175
Day's Range
0.17-0.17
Revenue
1.43M
Open
0.17
52 wk Range
0.135-0.346
EPS
-0.03
Volume
111,245
Market Cap
32.96M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
218,324
P/E Ratio
-
Beta
0.41
1-Year Change
-36.37%
Shares Outstanding
193,854,001
Next Earnings Date
-
What is your sentiment on Amplia Therapeutics Ltd?
or
Market is currently closed. Voting is open during market hours.

Amplia Therapeutics Ltd Company Profile

Employees
0
Market
Australia

Amplia Therapeutics Limited is an Australia-based clinical-stage drug development company. The Company’s pipeline is developing two orally available small molecule Focal Adhesion Kinase (FAK) inhibitors as candidate drugs for the treatment of cancer and various fibrotic diseases. Its initial clinical development pipeline consists of AMP945 and AMP886 (FLT3/VEGFR3). The Company’s cancer program uses its FAK inhibitors to block fibrosis and cell migration in cancers. Its Fibrosis Program is the formation of excessive fibrous connective tissues that can result from chronic inflammation, chronic injury or disease. Its FAK inhibitors have been shown to block fibrosis in established animal models of both lung fibrosis and liver fibrosis (NASH).

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralNeutralSellSellStrong Sell
Technical IndicatorsSellSellBuyStrong BuyStrong Sell
SummaryNeutralNeutralNeutralNeutralStrong Sell
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.